BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 207172)

  • 21. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 23. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood platelet function, medicinal agents, and other chemical entities.
    Lasslo A
    Fed Proc; 1984 Apr; 43(5):1382-9. PubMed ID: 6323230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional pool of cyclic adenosine 3',5'-monophosphate in rabbit platelets.
    Hashimoto S
    Thromb Haemost; 1983 Feb; 49(1):8-12. PubMed ID: 6302940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of CI-930, a novel phosphodiesterase III inhibitor, on platelet aggregation and arachidonic acid metabolism.
    Chen XS; Zeng HW; Jiang YY; Wan WQ; Long K
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):338-43. PubMed ID: 1966575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
    Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
    Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
    Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.
    Broekman MJ; Ward JW; Marcus AJ
    J Clin Invest; 1980 Aug; 66(2):275-83. PubMed ID: 7400315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhancement of platelet function in cholesterol-fed guinea-pigs].
    Maeda J; Tsuboi T; Fujitani B; Kadokawa T; Shimizu M
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):105-11. PubMed ID: 6293944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclic nucleotides and blood platelet functions].
    Kuramoto A
    Nihon Rinsho; 1978 Dec; 36(12):3813-8. PubMed ID: 34743
    [No Abstract]   [Full Text] [Related]  

  • 38. Mobilization of arachidonic acid in human platelets. Kinetics and Ca2+ dependency.
    Rittenhouse-Simmons S; Russell FA; Deykin D
    Biochim Biophys Acta; 1977 Sep; 488(3):370-80. PubMed ID: 901795
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway.
    Marcus AJ
    J Lipid Res; 1978 Sep; 19(7):793-826. PubMed ID: 101634
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid inactivation of cyclooxygenase activity after stimulation of intact platelets.
    Lapetina EG; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):121-5. PubMed ID: 218191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.